Search Results

There are 3220 results for: content related to: Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy

  1. You have free access to this content
    The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer

    Cancer

    Volume 121, Issue 8, April 15, 2015, Pages: E1–E6, Conor E. Steuer, Fadlo R. Khuri and Suresh S. Ramalingam

    Version of Record online : 17 DEC 2014, DOI: 10.1002/cncr.29139

  2. You have free access to this content
    The combination of irreversible EGFR TKIs and SAHA induces apoptosis and autophagy-mediated cell death to overcome acquired resistance in EGFRT790M-mutated lung cancer

    International Journal of Cancer

    Volume 136, Issue 11, 1 June 2015, Pages: 2717–2729, Tae-Gul Lee, Eun-Hui Jeong, Seo Yun Kim, Hye-Ryoun Kim and Cheol Hyeon Kim

    Version of Record online : 26 NOV 2014, DOI: 10.1002/ijc.29320

  3. You have free access to this content
    Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancer

    Cancer

    Volume 120, Issue 15, August 1, 2014, Pages: 2289–2298, Adrian G. Sacher, Pasi A. Jänne and Geoffrey R. Oxnard

    Version of Record online : 17 APR 2014, DOI: 10.1002/cncr.28723

  4. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer

    Intervention Review

    The Cochrane Library

    Janette Greenhalgh, Kerry Dwan, Angela Boland, Victoria Bates, Fabio Vecchio, Yenal Dundar, Pooja Jain and John A Green

    Published Online : 25 MAY 2016, DOI: 10.1002/14651858.CD010383.pub2

  5. You have free access to this content
    Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations

    Cancer

    Volume 120, Issue 14, 15 July 2014, Pages: 2090–2098, Youngjoo Lee, Geon Kook Lee, Yeon-Su Lee, Wenji Zhang, Jung-Ah Hwang, Byung-Ho Nam, Seok Hyun Kim, Joo-Hang Kim, Tak Yun, Ji-Youn Han, Heung Tae Kim and Jin Soo Lee

    Version of Record online : 15 APR 2014, DOI: 10.1002/cncr.28711

  6. Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells

    Molecular Carcinogenesis

    Volume 55, Issue 5, May 2016, Pages: 991–1001, Yongik Lee, Yian Wang, Michael James, Joseph H. Jeong and Ming You

    Version of Record online : 4 JUN 2015, DOI: 10.1002/mc.22342

  7. An activation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma

    The Journal of Pathology

    Volume 234, Issue 2, October 2014, Pages: 277–288, Kaito Nihira, Yasuhiro Miki, Shinya Iida, Sodai Narumi, Katsuhiko Ono, Erina Iwabuchi, Kazue Ise, Kazushige Mori, Mikiyoshi Saito, Masahito Ebina, Ikuro Sato, Makoto Maemondo, Hisafumi Yamada-Okabe, Takashi Kondo and Hironobu Sasano

    Version of Record online : 18 AUG 2014, DOI: 10.1002/path.4354

  8. You have full text access to this Open Access content
    Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer

    Molecular Oncology

    Volume 6, Issue 1, February 2012, Pages: 15–26, Rodrigo Dienstmann, Sara De Dosso, Enriqueta Felip, Josep Tabernero

    Version of Record online : 6 DEC 2011, DOI: 10.1016/j.molonc.2011.11.009

  9. You have full text access to this OnlineOpen article
    Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib

    Cancer Science

    Volume 106, Issue 10, October 2015, Pages: 1377–1384, Shinsuke Hashida, Hiromasa Yamamoto, Kazuhiko Shien, Yuichiro Miyoshi, Tomoaki Ohtsuka, Ken Suzawa, Mototsugu Watanabe, Yuho Maki, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyoshi and Shinichi Toyooka

    Version of Record online : 30 SEP 2015, DOI: 10.1111/cas.12749

  10. You have free access to this content
    A novel treatment strategy for EGFR mutant NSCLC with T790M-mediated acquired resistance

    International Journal of Cancer

    Volume 131, Issue 4, 15 August 2012, Pages: 970–979, Erika Taube, Elina Jokinen, Peppi Koivunen and Jussi P. Koivunen

    Version of Record online : 8 NOV 2011, DOI: 10.1002/ijc.26461

  11. You have full text access to this Open Access content
    Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor

    Cancer Science

    Volume 104, Issue 9, September 2013, Pages: 1198–1204, Kazuko Sakai, Atsushi Horiike, Darryl L. Irwin, Keita Kudo, Yoshihiko Fujita, Azusa Tanimoto, Toshio Sakatani, Ryota Saito, Kyohei Kaburaki, Noriko Yanagitani, Fumiyoshi Ohyanagi, Makoto Nishio and Kazuto Nishio

    Version of Record online : 1 JUL 2013, DOI: 10.1111/cas.12211

  12. You have free access to this content
    EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors

    The FEBS Journal

    Volume 277, Issue 2, January 2010, Pages: 316–326, Kenji Takeuchi and Fumiaki Ito

    Version of Record online : 18 NOV 2009, DOI: 10.1111/j.1742-4658.2009.07450.x

  13. You have full text access to this Open Access content
    Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

    Journal of Cellular and Molecular Medicine

    Volume 14, Issue 1-2, January-February 2010, Pages: 51–69, Luis Paz-Ares, Denis Soulières, Ivan Melezínek, Joachim Moecks, Lorenz Keil, Tony Mok, Rafael Rosell and Barbara Klughammer

    Version of Record online : 8 DEC 2009, DOI: 10.1111/j.1582-4934.2009.00991.x

  14. You have full text access to this Open Access content
    Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer

    Cancer Science

    Volume 98, Issue 12, December 2007, Pages: 1817–1824, Tetsuya Mitsudomi and Yasushi Yatabe

    Version of Record online : 20 SEP 2007, DOI: 10.1111/j.1349-7006.2007.00607.x

  15. You have full text access to this OnlineOpen article
    Clinical outcome of epidermal growth factor receptor-tyrosine kinase inhibitors therapy for patients with overlapping kirsten rat sarcoma 2 viral oncogene homolog and epidermal growth factor receptor gene mutations

    Thoracic Cancer

    Volume 7, Issue 1, January 2016, Pages: 24–31, Hong Zhang, Hua Bai, Xiaodan Yang, Jia Zhong, Tongtong An, Jun Zhao and Jie Wang

    Version of Record online : 11 JUN 2015, DOI: 10.1111/1759-7714.12266

  16. Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy

    Differentiation

    Volume 75, Issue 9, November 2007, Pages: 788–799, Floriana Morgillo, Maria Anna Bareschino, Roberto Bianco, Giampaolo Tortora and Fortunato Ciardiello

    Version of Record online : 2 JUL 2007, DOI: 10.1111/j.1432-0436.2007.00200.x

  17. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Version of Record online : 10 OCT 2014, DOI: 10.1002/jps.24113

  18. You have free access to this content
    Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors

    International Journal of Cancer

    Volume 137, Issue 12, 15 December 2015, Pages: 2947–2958, M.G. Dal Bello, A. Alama, G. Barletta, S. Coco, A. Truini, I. Vanni, S. Boccardo, C. Genova, E. Rijavec, F. Biello, G. Bottoni, G. Sambuceti and F. Grossi

    Version of Record online : 15 JUL 2015, DOI: 10.1002/ijc.29647

  19. Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck

    Head & Neck

    Volume 32, Issue 10, October 2010, Pages: 1412–1421, Mark E. Sharafinski, Robert L. Ferris, Soldano Ferrone and Jennifer R. Grandis

    Version of Record online : 26 MAR 2010, DOI: 10.1002/hed.21365

  20. You have free access to this content
    Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs

    International Journal of Cancer

    Volume 129, Issue 6, 15 September 2011, Pages: 1410–1416, Hidenori Tanaka, Tatsuo Kimura, Shinzoh Kudoh, Shigeki Mitsuoka, Tetsuya Watanabe, Tomohiro Suzumura, Keisei Tachibana, Masayuki Noguchi, Seiji Yano and Kazuto Hirata

    Version of Record online : 26 FEB 2011, DOI: 10.1002/ijc.25799